Status:
COMPLETED
Spinal Anaesthesia With Levobupivacaine 0.5% and Ropivacaine 0.75% for Lower Limb Orthopaedic Surgery
Lead Sponsor:
Aligarh Muslim University
Conditions:
Lower Limb Surgery
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the effects of two intrathecally administered drugs:0.5% levobupivacaine and0.75%Ropivacaine in spinal anesthesia
Detailed Description
Bupivacaine is a highly cardiotoxic drug and also produces prolonged motor blockade.The newer drugs levobupivacaine and ropivacaine being comparatively less cardio and neurotoxic are preferred now a d...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) class I \& II patients of either sex
- Age between 18-60 years
Exclusion
- Patient's refusal.
- Patients who have contraindications to spinal anaesthesia / Local anaesthetic drugs.
- Patients having h/o diabetes, neurological and musculoskeletal diseases.
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02201784
Start Date
December 1 2012
End Date
January 1 2014
Last Update
January 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jawaharlal Nehru medical college, AMU
Aligarh, Uttar Pradesh, India, 202002